Startups
Enterome

Enterome

https://enterome.com

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

Summary

Seedtable Score
  • 54
Locations
Company Size
  • 51 to 100 employees
Last Stage Round
  • Series F
Industry

Total funding Amount

$150M

Fundraising History

  • Oct 30 '23 Series F
    $3.2M
  • Jul 14 '22 Series F
    $43M
  • Jun 01 '20 Series E
    $52M
  • Jan 01 '17 Series D
    $35M
  • Apr 20 '16 Series C
    $16M
  • May 01 '14 Series B
    $12M
  • Mar 23 '12 Series A
    $8.2M
  • Jan 01 '11 Seed
    $1.6M

Investors

  • The Leukemia & Lymphoma Society’s Therapy Acceleration Program
    Series F
  • Nestlé Health Science
    Series C
  • Seventure Partners
    Seed
  • Omnes Capital
    Series A